Jennifer Velloza1,2, Sinead Delany-Moretlwe3, Jared M Baeten1,2,4. 1. Department of Global Health, University of Washington. 2. Department of Epidemiology, University of Washington, Seattle, USA. 3. Faculty of Health Sciences, Wits Reproductive Health & HIV Institute (WRHI), University of the Witwatersrand, Johannesburg, South Africa. 4. Department of Medicine, University of Washington, Seattle, USA.
Abstract
PURPOSE OF REVIEW: This review summarizes key HIV prevention strategies in the 2020 toolkit and discusses opportunities to maximize the public health impact of these prevention interventions at a population level. RECENT FINDINGS: HIV prevention has relied on counseling, HIV testing, and condom distribution for the past three decades. Recent exciting work has provided evidence on effective HIV prevention interventions, including antiretroviral therapy for HIV prevention, expanding preexposure prophylaxis modalities, and voluntary medical male circumcision which all reduce individual-level HIV risk. Efficient service-delivery approaches are necessary to deliver these products at scale while addressing population-specific needs. These approaches include: making it easier to get individuals HIV tested and linked to prevention services; de-medicalization to increase access to prevention products; creating welcoming clinic service-delivery environments; and integrating HIV prevention products into existing clinical platforms to support ongoing care engagement. SUMMARY: The 2020 HIV prevention toolkit includes powerful HIV prevention options, and product choice will be increasingly imperative. Meeting ambitious global HIV reduction targets in the next decade will require improved service-delivery platforms to get prevention choices to persons at risk while layering prevention coverage to achieve population-level impact.
PURPOSE OF REVIEW: This review summarizes key HIV prevention strategies in the 2020 toolkit and discusses opportunities to maximize the public health impact of these prevention interventions at a population level. RECENT FINDINGS: HIV prevention has relied on counseling, HIV testing, and condom distribution for the past three decades. Recent exciting work has provided evidence on effective HIV prevention interventions, including antiretroviral therapy for HIV prevention, expanding preexposure prophylaxis modalities, and voluntary medical male circumcision which all reduce individual-level HIV risk. Efficient service-delivery approaches are necessary to deliver these products at scale while addressing population-specific needs. These approaches include: making it easier to get individuals HIV tested and linked to prevention services; de-medicalization to increase access to prevention products; creating welcoming clinic service-delivery environments; and integrating HIV prevention products into existing clinical platforms to support ongoing care engagement. SUMMARY: The 2020 HIV prevention toolkit includes powerful HIV prevention options, and product choice will be increasingly imperative. Meeting ambitious global HIV reduction targets in the next decade will require improved service-delivery platforms to get prevention choices to persons at risk while layering prevention coverage to achieve population-level impact.
Authors: Danielle Giovenco; Audrey Pettifor; Kimberly A Powers; Lisa Hightow-Weidman; Brian W Pence; Jessie K Edwards; Katherine Gill; Jennifer F Morton; Ariane van der Straten; Connie Celum; Linda-Gail Bekker Journal: AIDS Behav Date: 2021-09-03
Authors: Elzette Rousseau; Ariana W K Katz; Shannon O'Rourke; Linda-Gail Bekker; Sinead Delany-Moretlwe; Elizabeth Bukusi; Danielle Travill; Victor Omollo; Jennifer F Morton; Gabrielle O'Malley; Jessica E Haberer; Renee Heffron; Rachel Johnson; Connie Celum; Jared M Baeten; Ariane van der Straten Journal: PLoS One Date: 2021-10-14 Impact factor: 3.752
Authors: Anthony J Eller; Elizabeth E DiDomizio; Lynn M Madden; Jennifer D Oliva; Frederick L Altice; Kimberly A Johnson Journal: Ann Med Date: 2022-07-01 Impact factor: 5.348
Authors: Pamela Y Collins; Jennifer Velloza; Tessa Concepcion; Linda Oseso; Lydia Chwastiak; Christopher G Kemp; Jane Simoni; Bradley H Wagenaar Journal: J Int AIDS Soc Date: 2021-06 Impact factor: 5.396